Action mechanisms of galectin-1, CNTF and phosphacan for the regulation of axonal regeneration
Action mechanisms of galectin-1, CNTF and phosphacan for the regulation of axonal regeneration
批准号:
17500267
负责人:
SANGO Kazunori
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We investigated the action mechanisms of growth-promoting molecules such as oxidized galectin-1 and ciliary neurotrophic factor (CNTF) and regulatory molecules such as chondroitin sulfate proteoglycans (especially phosphacan) in axonal regeneration after injury.(1)Galectin-1 and CNTF : Immunohistochemistry on the sections of adult rat dorsal root ganglia (DRG) revealed that galectin-1 was abundantly expressed in small-diameter sensory neurons and Schwann cells while CNTF expression was restricted to Schwann cells. In contrast to the findings in vivo, we observed intense immunoreactivity for both galectin-1 and CNTF in DRG neurons after 3 hours, 2 days and 7 days in culture. At later stages of culture, the immunoreactivity was detected in regenerating neurites. These results suggest that both molecules are synthesized and transported to neurites in cultured DRG neurons. In spite of lacking signal leading sequences, galectin-1 is likely to be externalized from intact DRG neurons and Schw … More ann cells through the non-classical secretory pathway, whereas CNTF appears to be released from disrupted Schwann cells after peripheral nerve injury. Galectin-1 converted from the reduced form to the oxidized form in the extracellular space is likely to stimulate macrophages to secrete several factors (e.g. interleukin-6, bran derived neurotrophic factor), while CNTF directly acts on DRG neurons to activate signal transduction pathways (e.g. JAK-STAT3, MEK-MAPK, PI3K-Akt).(2)Chondroitin sulfate proteoglycans : Phosphacan purified from embryonic (E20) or postnatal (P7, P20) rat brain impaired attachment and neurite outgrowth of cultured adult rat DRG neurons. These inhibitory effects were dependent on dose (10μg/ml>1μg/ml>>0.1μg/ml) and age of rats from which the molecule was purified (P20>P7>E20). Since the structure of chondroitin sulfate of these preparations are immunologically and compositionally different, these findings suggest that variation of chondroitin sulfate chains plays important roles in the regulatory actions of phosphacan. Less
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Neural Proteoglycans
神经蛋白多糖
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Masu M., et. al.]
通讯作者:
et. al.
Chondroitin sulfate proteoglycans in the peripheral nervous system after injury.
损伤后周围神经系统中的硫酸软骨素蛋白多糖。
DOI:
--
发表时间:
期刊:
Neural Proteoglycans (Maeda, N., ed.)(Research Signpost Kerala, India) (in press)
影响因子:
--
作者:
[Sango, K.]
通讯作者:
K.
An approach to the pathogenesis of diabetic neuropathy with cultured adult animal neurons and Schwann cells. (Japanese)
利用培养的成年动物神经元和施万细胞研究糖尿病神经病变的发病机制。
DOI:
--
发表时间:
2006
期刊:
Peripheral Nerve (Massho Shinkei) 17
影响因子:
--
作者:
[Sango, K., Saito, H., Horie, H.]
通讯作者:
H.
Medicines for diabetic complications.(Japanese)
治疗糖尿病并发症的药物。(日语)
DOI:
--
发表时间:
2005
期刊:
Prospects of New Medicines (Shinyaku Tenbo) 41(S-1)
影响因子:
--
作者:
[Sango, K.]
通讯作者:
K.
Establishment of immortalized Schwann cells from a Sandhoff mouse and corrective effect of recombinant human β- hexosaminidase A on the accumulated GM2 ganglioside
Sandhoff小鼠永生雪旺细胞的建立及重组人β-氨基己糖苷酶A对GM2神经节苷脂积累的纠正作用
DOI:
--
发表时间:
2005
期刊:
Journal of Human Genetics 50
影响因子:
--
作者:
[Ohsawa, M., Kotani, M., Tajima, Y., Tsuji, D., Ishibashi, Y., Kuroki, A., Itoh, K., Watabe, K., Sango, K., Yamanaka, Y., Sakuraba, H.]
通讯作者:
H.
共 21 条
Approaches to peripheral neuropathies utilizing multi-analysis system among neurons, Schwann cells and vascular endothelial cells
-
批准号:20K07773
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:SANGO Kazunori
-
依托单位:
Immortalized adult rodent Schwann cells as useful tools for the study of peripheral neuropathies
-
批准号:16K07048
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2016
-
负责人:SANGO Kazunori
-
依托单位:
Coculture of neuronal and Schwann cell lines as a useful tool for the study of peripheral nerve degeneration and regeneration
-
批准号:25430056
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2013
-
负责人:SANGO Kazunori
-
依托单位:
Peripheral nerve degeneration and regeneration from the viewpoint of neuron-Schwann cell interplay
-
批准号:22500324
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:SANGO Kazunori
-
依托单位:
Mechanisms of gene regulation and action of neuroprotective factors
-
批准号:19500337
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:SANGO Kazunori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
丹参提取物抑制Galectin- 1靶向RACK1改善糖尿病肾损伤的机制研究
-
批准号:2026JJ82135
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邓薇
-
依托单位:
雷公藤红素靶向Galectin-1/LAMP1通路重塑溶酶体胆固醇稳态触发免疫原性细胞死亡抗肾癌作用
-
批准号:2026JJ30080
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:覃丽
-
依托单位:
鸦胆子苦素A抑制Galectin-1靶向RACK1改善酒精性肾损伤的机制研究
-
批准号:2025JJ90093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈莉
-
依托单位:
CAFs源性Galectin-1调控“TTK-TP53-TGF-β1”信号通路增强胃癌细胞失巢凋亡抵抗促进胃癌腹膜转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:尤小兰
-
依托单位:
离不扑皂苷靶向Galectin-1抑制足细胞EMT改善肾损伤的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:--
-
依托单位:
三氧化二砷纳米靶向调控PSCs的Galectin-1表达重塑胰腺癌免疫微环境增敏免疫治疗的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:李佳佳
-
依托单位:
Galectin-1抑制肺泡巨噬细胞线粒体损伤介导的NLRP3活化减轻流感致急性肺损伤的机制研究
-
批准号:82300005
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:包佳琪
-
依托单位:
Galectin-1减少缺血神经元死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
脂肪细胞来源Galectin-1调节PSCs甘油三酯代谢促进胰腺癌进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
Galectin-1与CLEC-2结合介导血小板与内皮细胞黏附在肝硬化门静脉血栓形成中的作用
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:祁兴顺
-
依托单位: